Vanda Pharmaceuticals (VNDA) Net Margin (2010 - 2026)
Vanda Pharmaceuticals (VNDA) reported Net Margin of 93.82% for Q1 2026, down 3488.0% on a YoY basis from 2.77% in Q1 2025, and up 61.98% sequentially from 246.76% in Q4 2025.
Vanda Pharmaceuticals (VNDA) Net Margin (2010 - 2026) Analysis & Trends
Vanda Pharmaceuticals (VNDA) has 17 years of Net Margin data on file, last reported at 93.82% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin fell 3488.0% year-over-year to 93.82%; the trailing twelve-month figure through Mar 2026 stood at 109.97% (down 8800.0% YoY), and the FY2025 full-year result was 102.02%, down 9251.0% from the prior year.
- Net Margin advanced to 93.82% in Q1 2026, from 246.76% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 10.64% in Q4 2022 to a low of 246.76% in Q4 2025.
- A 5-year average of 30.41% and a median of 8.95% in 2024 frame the typical range for Net Margin.
- Across the five-year window, Net Margin surged 1590 bps in 2023 and plunged 23759 bps in 2025, its largest moves.
- Tracing VNDA's Net Margin over 5 years: stood at 10.64% in 2022, then plunged by 150 bps to 5.28% in 2023, then sank by 74 bps to 9.17% in 2024, then tumbled by 2592 bps to 246.76% in 2025, then jumped by 62 bps to 93.82% in 2026.
- Business Quant data shows VNDA's Net Margin at 93.82% in Q1 2026, 246.76% in Q4 2025, and 40.15% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Vanda Pharmaceuticals | 318.71 Mn | 116.40 Mn | 48.56 Mn | -93.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -93.82% |
| Dec 31, 2025 | -246.76% |
| Sep 30, 2025 | -40.15% |
| Jun 30, 2025 | -51.70% |
| Mar 31, 2025 | -58.94% |
| Dec 31, 2024 | -9.17% |
| Sep 30, 2024 | -11.21% |
| Jun 30, 2024 | -8.95% |
| Mar 31, 2024 | -8.74% |
| Dec 31, 2023 | -5.28% |
| Sep 30, 2023 | 0.35% |
| Jun 30, 2023 | 3.24% |
| Mar 31, 2023 | 5.16% |
| Dec 31, 2022 | 10.64% |
| Sep 30, 2022 | 4.99% |
| Jun 30, 2022 | 4.02% |
| Mar 31, 2022 | -10.74% |
| Dec 31, 2021 | 10.41% |
| Sep 30, 2021 | 11.02% |
| Jun 30, 2021 | 14.22% |